Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bayer Ag Ord (OP: BAYZF ) 27.73 UNCHANGED Streaming Delayed Price Updated: 3:08 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 48 Open 27.73 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 27.73 Today's Range 27.73 - 27.73 52wk Range 26.91 - 58.93 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M June 05, 2024 Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation. Via Benzinga Exposures Glyphosate After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February May 24, 2024 Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. Via Benzinga Topics Data Breach Exposures Information Security Performance YTD -26.55% -26.55% 1 Month -9.13% -9.13% 3 Month -3.90% -3.90% 6 Month -23.49% -23.49% 1 Year -50.27% -50.27% More News Read More Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval May 17, 2024 Via Benzinga Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned May 02, 2024 Via Benzinga Exposures Glyphosate Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant March 19, 2024 Via Benzinga Exposures Product Safety German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits March 14, 2024 Via Benzinga Topics Bankruptcy Lawsuit Exposures Financial Glyphosate Legal Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges March 05, 2024 Via Benzinga What's Going On With BridgeBio Pharma Stock On Monday? March 04, 2024 Via Benzinga Exposures Product Safety Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial January 30, 2024 Via Benzinga Topics Lawsuit Exposures Financial Glyphosate Legal Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout January 29, 2024 Via Benzinga Exposures Glyphosate Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance January 11, 2024 Via Benzinga Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial January 08, 2024 Via Benzinga Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial January 04, 2024 Via Benzinga Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak December 26, 2023 Via Benzinga Topics Lawsuit Exposures Financial Glyphosate Legal ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US December 19, 2023 Via Benzinga Topics Climate Change Exposures Climate Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss December 06, 2023 Via Benzinga Exposures Glyphosate Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion December 04, 2023 Via Benzinga Topics Lawsuit Exposures Financial Glyphosate Legal German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks November 24, 2023 Via Benzinga Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence November 20, 2023 Via Benzinga Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details November 20, 2023 Via Benzinga Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits November 17, 2023 Via Benzinga Topics Lawsuit Exposures Financial Legal Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss November 08, 2023 Via Benzinga Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss November 01, 2023 Via Benzinga Exposures Glyphosate From Years to Months: How AI is Shaping the Landscape of Clinical Trials September 22, 2023 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories August 28, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.